Harbour Investments’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.99K | Buy |
+3,559
| New | +$3.99K | ﹤0.01% | 2960 |
|
|
2023
Q4 | – | Sell |
-53
| Closed | -$159 | – | 3132 |
|
|
2023
Q3 | $159 | Sell |
53
-45
| -46% | -$135 | ﹤0.01% | 2900 |
|
|
2023
Q2 | $3.04K | Hold |
98
| – | – | ﹤0.01% | 2430 |
|
|
2023
Q1 | $4.87K | Sell |
98
-21
| -18% | -$1.04K | ﹤0.01% | 2283 |
|
|
2022
Q4 | $2.92K | Sell |
119
-57
| -32% | -$1.4K | ﹤0.01% | 2415 |
|
|
2022
Q3 | $7K | Hold |
176
| – | – | ﹤0.01% | 2046 |
|
|
2022
Q2 | $7K | Buy |
+176
| New | +$7K | ﹤0.01% | 2046 |
|
|
2021
Q4 | $18K | Sell |
293
-258
| -47% | -$15.9K | ﹤0.01% | 1701 |
|
|
2021
Q3 | $27K | Sell |
551
-79
| -13% | -$3.87K | ﹤0.01% | 2126 |
|
|
2021
Q2 | $36K | Hold |
630
| – | – | ﹤0.01% | 1986 |
|
|
2021
Q1 | $36K | Buy |
+630
| New | +$36K | ﹤0.01% | 1865 |
|